Involvement of calcium and G proteins in the acute release of tissue-type plasminogen activator and von Willebrand factor from cultured human endothelial cells
- PMID: 9351387
- DOI: 10.1161/01.atv.17.10.2177
Involvement of calcium and G proteins in the acute release of tissue-type plasminogen activator and von Willebrand factor from cultured human endothelial cells
Abstract
In this study, we investigated the role of Ca2+ and G proteins in thrombin-induced acute release (regulated secretion) of tissue-type plasminogen activator (TPA) and von Willebrand factor (vWF), using a previously described system of primary human umbilical vein endothelial cells (HUVECs). The acute release of TPA and vWF, as induced by alpha-thrombin, was almost zero after chelation of Ca2+i, showing that an increase in [Ca2+]i was required. It did not matter whether the increase in [Ca2+]i came from an intracellular or extracellular Ca2+ source. Thrombin-induced release of TPA and vWF already started at low [Ca2+]i, around 100 nmol/L. Half-maximal release was found at a [Ca2+]i, of 261 nmol/L for TPA and at 222 nmol/L for vWF. The Ca2+ signal was transduced to calmodulin, as calmodulin inhibitors inhibited TPA and vWF release. The Ca2+ ionophore ionomycin dose dependently released vWF; half-maximal vWF release occurred at a [Ca2+]i of 311 nmol/L. In contrast, no TPA release was found at all below a [Ca2+]i of 500 nmol/L. Thus, below 500 nmol/L [Ca2+]i, an increase in [Ca2+]i alone was sufficient to induce vWF release but not sufficient to induce TPA release. Protein kinase C did not appear to be involved in TPA or vWF release, as neither an activator nor an inhibitor of protein kinase C significantly influenced release. Inhibition of phospholipase A2 also did not reduce thrombin-induced TPA and vWF release. The involvement of G proteins was studied by using both saponin-permeabilized and intact cells. GDP-beta-S, which inhibits heterotrimeric and small G proteins, significantly inhibited thrombin-induced vWF and TPA release from permeabilized cells. AlF-4, which activates heterotrimeric G proteins, induced TPA and vWF release in both intact and permeabilized HUVECs. Preincubation of HUVECs with pertussis toxin significantly inhibited thrombin-induced vWF release, due to inhibition of thrombin-induced Ca2+ influx. Pertussis toxin did not affect ionomycin-induced release. The inhibitory effect of pertussis toxin was less obvious in thrombin-induced TPA release, because it was counterbalanced by a positive effect of the toxin on TPA release. Thus, both inhibitory and stimulatory (pertussis toxin-sensitive) G proteins were involved in TPA release. Therefore, thrombin-induced acute release of TPA and vWF differed in two respects. First, below a [Ca2+]i of 500 nmol/L, an increase in Ca2+ was sufficient for vWF release but not for TPA release. Second, pertussis toxin-sensitive G proteins were differentially involved in acute TPA and vWF release.
Similar articles
-
Adenosine 3':5'-cyclic monophosphate induces regulated secretion of tissue-type plasminogen activator and von Willebrand factor from cultured human endothelial cells.Thromb Haemost. 1998 Apr;79(4):853-8. Thromb Haemost. 1998. PMID: 9569204
-
Calcium/calmodulin transduces thrombin-stimulated secretion: studies in intact and minimally permeabilized human umbilical vein endothelial cells.J Cell Biol. 1992 Sep;118(6):1501-10. doi: 10.1083/jcb.118.6.1501. J Cell Biol. 1992. PMID: 1522120 Free PMC article.
-
Protein tyrosine kinases regulate agonist-stimulated prostacyclin release but not von Willebrand factor secretion from human umbilical vein endothelial cells.Biochem J. 1996 Apr 15;315 ( Pt 2)(Pt 2):407-16. doi: 10.1042/bj3150407. Biochem J. 1996. PMID: 8615807 Free PMC article.
-
G-proteins and endothelial responses.Blood Vessels. 1990;27(2-5):218-29. doi: 10.1159/000158813. Blood Vessels. 1990. PMID: 2122922 Review.
-
The control of production and release of haemostatic factors in the endothelial cell.Baillieres Clin Haematol. 1993 Sep;6(3):629-51. doi: 10.1016/s0950-3536(05)80192-1. Baillieres Clin Haematol. 1993. PMID: 8025346 Review.
Cited by
-
Cav3.1 (alpha1G) controls von Willebrand factor secretion in rat pulmonary microvascular endothelial cells.Am J Physiol Lung Cell Mol Physiol. 2007 Apr;292(4):L833-44. doi: 10.1152/ajplung.00377.2006. Epub 2006 Dec 15. Am J Physiol Lung Cell Mol Physiol. 2007. PMID: 17172292 Free PMC article.
-
von-Willebrand factor influences blood brain barrier permeability and brain inflammation in experimental allergic encephalomyelitis.Am J Pathol. 2008 Sep;173(3):892-900. doi: 10.2353/ajpath.2008.080001. Epub 2008 Aug 7. Am J Pathol. 2008. PMID: 18688020 Free PMC article.
-
An endothelial storage granule for tissue-type plasminogen activator.J Cell Biol. 1997 Oct 6;139(1):245-56. doi: 10.1083/jcb.139.1.245. J Cell Biol. 1997. PMID: 9314543 Free PMC article.
-
Membrane capacitance changes induced by thrombin and calcium in single endothelial cells cultured from human umbilical vein.J Physiol. 1998 Dec 15;513 ( Pt 3)(Pt 3):845-55. doi: 10.1111/j.1469-7793.1998.845ba.x. J Physiol. 1998. PMID: 9824722 Free PMC article.
-
Endothelium-derived hyperpolarizing factor mediates bradykinin-stimulated tissue plasminogen activator release in humans.J Vasc Res. 2014;51(3):200-8. doi: 10.1159/000362666. Epub 2014 Jun 4. J Vasc Res. 2014. PMID: 24925526 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous